Utility of multiparametric renal CT for differentiation of low-grade from high-grade cT1a clear cell renal cell carcinoma.

Abstract

To determine if CT can differentiate low-grade from high-grade clear cell renal cell carcinoma (ccRCC) in cT1a solid ccRCC. This retrospective cross-sectional study evaluated 78 < 4 cm solid (>25% enhancing) ccRCC in 78 patients with renal CT within 12 months of surgery between January 2016 and December 2019. Two radiologists (R1/R2), blinded to pathology, independently recorded mass:size, calcification, attenuation and heterogeneity (5-point Likert scale) and recorded a 5-point ccRCC CT Score. Multivariate logistic regression (LR) was performed. There were 64.1% (50/78) low-grade (5/50 Grade 1 and 45/50 Grade 2) and 35.9% (28/78) high-grade (27/28 Grade 3 and 1/28 Grade 4) tumors.Unenhanced CT attenuation was higher (35.9±10.3 R1 and 34.9±10.7 R2 high-grade vs 29.7±10.2 R1 and 29.5±9.8 R2 low-grade, p=0.01-0.02), absolute corticomedullary phase attenuation ratio (CMphase-ratio; 0.67±0.16 R1 and 0.66±0.16 R2 vs 0.93±0.83 R1 and 0.80±0.33 R2, p=0.04-0.05) and 3-tiered stratification of CMphase-ratio (p=0.02) lower in high-grade tumors.A two-variable LR-model including unenhanced CT attenuation and CM.phase-ratio achieved area under the receiver operator characteristic curve of: 73% (95% confidence intervals 59-86%) and 72% (59-84%) for R1 and R2.ccRCC CT score differed by ccRCC grade (p<0.01 R1, R2) with high-grade tumors occurring most commonly in moderately enhancing ccRCC score 4 (46.4% [13/28] R1 and 54% [15/28]). Among cT1a ccRCC, high-grade tumors have higher unenhanced CT attenuation and are less avidly enhancing. High-grade ccRCC have higher attenuation (possibly due to less microscopic fat) and lower corticomedullary phase enhancement compared to low-grade tumors. This may result in categorization of high-grade tumors in lower ccRCC diagnostic algorithm categories.